Ikervis

Ikervis is a medicine authorised by Swissmedic under authorisation number 66093. The authorisation holder is Santen SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 September 2016 and the authorisation is valid without a time limit. ATC code S01XA18 places the medicine in the group Ophthalmologicals.

  • Dispensing category B
  • Authorisation number 66093
  • ATC S01XA18
  • Synthetic medicines
Authorisation data
Authorisation number66093
NameIkervis
Full nameIkervis, 1 mg/ml collyre en émulsion (unidoses)
Authorisation holderSanten SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeS01XA18
First authorisation08 September 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Ikervis, 1 mg/ml collyre en émulsion (unidoses)B08 September 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130 x 0.3 mlEinzeldose(n)S01XA1811.99.0.B
290 x 0.3 mlEinzeldose(n)S01XA1811.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Ikervis authorised in Switzerland?

Yes. Ikervis is authorised by Swissmedic under authorisation number 66093, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ikervis have?

Ikervis is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ikervis?

The authorisation holder is Santen SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com